Literature DB >> 14978661

Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease.

Carlos Gonzalez-Juanatey1, Ana Testa, Alberto Garcia-Castelo, Carlos Garcia-Porrua, Javier Llorca, William E R Ollier, Miguel A Gonzalez-Gay.   

Abstract

OBJECTIVE: To assess the frequency of echocardiographic and Doppler abnormalities in long-term treated rheumatoid arthritis (RA) patients without clinically evident cardiovascular manifestations.
METHODS: Forty-seven patients with RA were recruited from Hospital Xeral-Calde, Lugo, Spain. Patients were required to have been treated for at least 5 years and to be on treatment with 1 or more disease-modifying antirheumatic drugs. Patients seen during the period of recruitment who had cardiovascular risk factors or had suffered cardiovascular or cerebrovascular events were excluded. Forty-seven healthy matched controls were also studied. Echocardiographic and Doppler studies were performed in all cases and controls. Patients were HLA-DRB1 genotyped by using molecular-based methods.
RESULTS: In patients with RA, the prevalence of aortic regurgitation (17%) and tricuspid regurgitation (17%) was not higher than that seen in controls (15% and 6%). The pulmonary artery systolic pressure was higher in patients with RA (30.3 +/- 8.0 mm Hg) than in controls (26.2 +/- 4.8) (P =.004). Incidence of pulmonary artery systolic pressure >35 mm Hg was significantly higher in patients with RA (21% versus 4% in controls; P =.03). Diastolic dysfunction caused by impaired relaxation was also more common in patients with RA (66%) than in controls (43%) (P =.02). It was more frequent in the older patients. Extra-articular manifestations were more common in patients with RA with diastolic dysfunction (P =.05). The HLA-DRB1 genotype was not implicated in the risk of developing diastolic dysfunction.
CONCLUSIONS: The present study confirms a high frequency of left ventricular diastolic dysfunction and pulmonary hypertension in patients with RA without evident cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978661     DOI: 10.1053/j.semarthrit.2003.09.011

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  27 in total

Review 1.  Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps.

Authors:  Thomas Zegkos; George Kitas; Theodoros Dimitroulas
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-04-30       Impact factor: 5.346

2.  Early Wave Reflection and Pulse Wave Velocity Are Associated with Diastolic Dysfunction in Rheumatoid Arthritis.

Authors:  Lebogang Mokotedi; Sulé Gunter; Chanel Robinson; Frederic Michel; Ahmed Solomon; Gavin R Norton; Angela J Woodiwiss; Linda Tsang; Patrick H Dessein; Aletta M E Millen
Journal:  J Cardiovasc Transl Res       Date:  2019-05-22       Impact factor: 4.132

3.  Relationship between matrix metalloproteinase-3 serum level and pulmonary artery systolic pressure in patients with rheumatoid arthritis.

Authors:  Tetsuro Sugiura; Mikio Kamioka; Shigeo Yamanaka; Taisuke Hisahara; Yoko Hirakawa; Yoshihisa Matsumura
Journal:  Heart Vessels       Date:  2017-08-21       Impact factor: 2.037

Review 4.  [Echocardiographic functional analysis of patients with rheumatoid arthritis and collagen diseases].

Authors:  A Hagendorff; D Pfeiffer
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

Review 5.  Rheumatoid arthritis and the heart.

Authors:  Hilal Maradit Kremers; Sherine E Gabriel
Journal:  Curr Heart Fail Rep       Date:  2006-06

Review 6.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

7.  Diastolic heart function in RA patients.

Authors:  M Wislowska; B Jaszczyk; M Kochmański; S Sypuła; M Sztechman
Journal:  Rheumatol Int       Date:  2007-10-24       Impact factor: 2.631

8.  Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study.

Authors:  Valentina O Puntmann; Peter C Taylor; Andrew Barr; Bernhard Schnackenburg; Cosima Jahnke; Ingo Paetsch
Journal:  Rheumatology (Oxford)       Date:  2009-12-21       Impact factor: 7.580

Review 9.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

Review 10.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.